In summary, while oleuropein increased the proteolytic activities of the 20S proteasome in all three HD cell models, it did not do so by modulating the major proteasome catalytic subunit and its PA28γ activator, or the MAPK, ROCKS, and the Nrf2 pathways. Here, NFE2L2 is linked to Huntington disease.